2015-2019 U.S. Enteric Disease Testing Market Outlook and Emerging Opportunities

September 2015 | 322 pages | ID: 2244138F778EN
Venture Planning Group

Abstracts

About This ReportThis new 322-page report from VPGMarketResearch presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial and Public Health Labs. In addition to market share and sales forecasts, the report:- Examines market applications of Molecular Diagnostics,Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;- Reviews features and operating characteristics of major analyzers usedfor microbiology testing; - Profiles key suppliers and potential market entrants developing innovativetechnologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies,market entry barriers/risks, and strategic planning issues. MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer productand financial literature, as well as VPGMarketResearchs proprietary data files was conducted. Contains 322 pages and 22 tables

Contents

1. INTRODUCTION

2. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Infectious Disease Tests
  1. CAMPYLOBACTER
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  2. CRYPTOSPORIDIUM
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  3. E. COLI
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  4. ENTEROVIRUSES
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  5. RHINOVIRUSES
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  6. ROTAVIRUS (REOVIRUS)
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  7. SALMONELLOSIS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  8. SHIGELLOSIS
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  9. VIBRIO
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
  10. YERSINIA
    a. Background
    b. Diagnostic Tests
    c. Vaccines and Drugs
B. INSTRUMENTATION REVIEW of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, OrthoClinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
  1. MOLECULAR DIAGNOSTICS
  2. MONOCLONAL ANTIBODIES
  3. IMMUNOASSAYS
  4. DIFFERENTIAL LIGHT SCATTERING
  5. INFORMATION TECHNOLOGY
  6. ARTIFICIAL INTELLIGENCE
  7. LIPOSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. DIAGNOSTIC IMAGING
  11. GEL MICRODROPLETS
  12. OTHER

9. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
BioRad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/GenProbe
ID Biomedical/GSK
Kreatech/Leica
Lonza
OrthoClinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Yersinia Tests
U.S.A. Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Campylobacter Diagnostics Sales by Major Supplier
U.S.A. Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Cryptosporidium Diagnostics Sales by Major Supplier
U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Enterovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rotavirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Salmonella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment